{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:20:51Z","timestamp":1763227251150},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.7759\/cureus.39818","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:19:58Z","timestamp":1685611198000},"source":"Crossref","is-referenced-by-count":2,"title":["Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing"],"prefix":"10.7759","author":[{"given":"Mohiuddin M","family":"Taher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najwa A","family":"Bantan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa H","family":"Alwalily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuha M","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Bouzidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raid A","family":"Jastania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal B","family":"Balkhoyour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1989.70.1.0024","article-title":"Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome","volume":"70","author":"Neumann HP","year":"1989","unstructured":"Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989, 70:24-30. 10.3171\/jns.1989.70.1.0024","journal-title":"J Neurosurg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.11.173","article-title":"Hemangioblastomas of the posterior cranial fossa in adults: demographics, clinical, morphologic, pathologic, surgical features, and outcomes. A systematic review","volume":"110","author":"Kuharic M","year":"2018","unstructured":"Kuharic M, Jankovic D, Splavski B, Boop FA, Arnautovic KI. Hemangioblastomas of the posterior cranial fossa in adults: demographics, clinical, morphologic, pathologic, surgical features, and outcomes. A systematic review. World Neurosurg. 2018, 110:e1049-62. 10.1016\/j.wneu.2017.11.173","journal-title":"World Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.07.082","article-title":"2016 World Health Organization classification of central nervous system tumors: an era of molecular biology","volume":"94","author":"Hoshide R","year":"2016","unstructured":"Hoshide R, Jandial R. 2016 World Health Organization classification of central nervous system tumors: an era of molecular biology. World Neurosurg. 2016, 94:561-2. 10.1016\/j.wneu.2016.07.082","journal-title":"World Neurosurg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis DN","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al.. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016, 131:803-20. 10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200101000-00009","article-title":"Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease","volume":"48","author":"Conway JE","year":"2001","unstructured":"Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001, 48:55-62; discussion 62-3. 10.1097\/00006123-200101000-00009","journal-title":"Neurosurgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/1793-5482.165782","article-title":"Supratentorial haemangioblastoma without von Hippel-Lindau syndrome in an adult: a rare tumor with review of literature","volume":"11","author":"Pandey S","year":"2016","unstructured":"Pandey S, Sharma V, Pandey D, Kumar V, Kumar M. Supratentorial haemangioblastoma without von Hippel-Lindau syndrome in an adult: a rare tumor with review of literature. Asian J Neurosurg. 2016, 11:8-14. 10.4103\/1793-5482.165782","journal-title":"Asian J Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2022.07.014","article-title":"Supratentorial hemangioblastoma: a rare case report and literature review","volume":"17","author":"Chang KC","year":"2022","unstructured":"Chang KC, Hsieh CT, Huang JS. Supratentorial hemangioblastoma: a rare case report and literature review. Radiol Case Rep. 2022, 17:4156-60. 10.1016\/j.radcr.2022.07.014","journal-title":"Radiol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000159646.15026.d6","article-title":"Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management","volume":"56","author":"Catapano D","year":"2005","unstructured":"Catapano D, Muscarella LA, Guarnieri V, Zelante L, D'Angelo VA, D'Agruma L. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery. 2005, 56:1215-21; discussion 1221. 10.1227\/01.neu.0000159646.15026.d6","journal-title":"Neurosurgery"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease","volume":"115","author":"Wong WT","year":"2008","unstructured":"Wong WT, Agr\u00f3n E, Coleman HR, Tran T, Reed GF, Csaky K, Chew EY. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology. 2008, 115:181-8. 10.1016\/j.ophtha.2007.03.009","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3171\/2008.4.17532","article-title":"Pituitary stalk hemangioblastomas in von Hippel-Lindau disease","volume":"110","author":"Lonser RR","year":"2009","unstructured":"Lonser RR, Butman JA, Kiringoda R, Song D, Oldfield EH. Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2009, 110:350-3. 10.3171\/2008.4.17532","journal-title":"J Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2370-6","article-title":"Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis","volume":"17","author":"Mehrian-Shai R","year":"2016","unstructured":"Mehrian-Shai R, Yalon M, Moshe I, et al.. Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis. BMC Genomics. 2016, 17:56. 10.1186\/s12864-016-2370-6","journal-title":"BMC Genomics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-4608(01)00578-7","article-title":"Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma","volume":"133","author":"Lemeta S","year":"2002","unstructured":"Lemeta S, Aalto Y, Niemel\u00e4 M, et al.. Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma. Cancer Genet Cytogenet. 2002, 133:174-8. 10.1016\/s0165-4608(01)00578-7","journal-title":"Cancer Genet Cytogenet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0167-x","article-title":"Sporadic hemangioblastomas are characterized by cryptic VHL inactivation","volume":"2","author":"Shankar GM","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N, et al.. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014, 2:167. 10.1186\/s40478-014-0167-x","journal-title":"Acta Neuropathol Commun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205149","article-title":"Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome","volume":"21","author":"Lui WO","year":"2002","unstructured":"Lui WO, Chen J, Gl\u00e4sker S, et al.. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome. Oncogene. 2002, 21:1117-22. 10.1038\/sj.onc.1205149","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1023\/a:1010623119469","article-title":"Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization","volume":"52","author":"Sprenger SH","year":"2001","unstructured":"Sprenger SH, Gijtenbeek JM, Wesseling P, Sciot R, van Calenbergh F, Lammens M, Jeuken JW. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization. J Neurooncol. 2001, 52:241-7. 10.1023\/a:1010623119469","journal-title":"J Neurooncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00703","article-title":"Overexpression of EGFR and TGF\u03b1 in von Hippel-Lindau-related central nervous system hemangioblastomas","author":"Liu Z","year":"2020","unstructured":"Liu Z, Li L, Yi Z, et al.. Overexpression of EGFR and TGF\u03b1 in von Hippel-Lindau-related central nervous system hemangioblastomas. Front Oncol. 2020, 10:703. Accessed: May 2020: https:\/\/doi.org\/10.3389\/fonc.2020.00703.. 10.3389\/fonc.2020.00703"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1983-y","article-title":"Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas","volume":"126","author":"Ta\u00efeb D","year":"2016","unstructured":"Ta\u00efeb D, Barlier A, Yang C, et al.. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. J Neurooncol. 2016, 126:473-81. 10.1007\/s11060-015-1983-y","journal-title":"J Neurooncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0203-x","article-title":"Next-generation sequencing to guide cancer therapy","volume":"7","author":"Gagan J","year":"2015","unstructured":"Gagan J, Van Allen EM. Next-generation sequencing to guide cancer therapy. Genome Med. 2015, 7:80. 10.1186\/s13073-015-0203-x","journal-title":"Genome Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.01.005","article-title":"Optimization of next-generation sequencing technologies for von Hippel Lindau (VHL) mosaic mutation detection and development of confirmation methods","volume":"21","author":"Coppin L","year":"2019","unstructured":"Coppin L, Plouvier P, Cr\u00e9pin M, et al.. Optimization of next-generation sequencing technologies for von Hippel Lindau (VHL) mosaic mutation detection and development of confirmation methods. J Mol Diagn. 2019, 21:462-70. 10.1016\/j.jmoldx.2019.01.005","journal-title":"J Mol Diagn"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18721.2","article-title":"Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing","volume":"8","author":"Butt E","year":"2019","unstructured":"Butt E, Alyami S, Nageeti T, et al.. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing. F1000Res. 2019, 8:613. 10.12688\/f1000research.18721.2","journal-title":"F1000Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S243405","article-title":"Adamantinomatous craniopharyngioma in an adult: a case report with NGS analysis","volume":"13","author":"Jastania RA","year":"2020","unstructured":"Jastania RA, Saeed M, Al-Khalidi H, et al.. Adamantinomatous craniopharyngioma in an adult: a case report with NGS analysis. Int Med Case Rep J. 2020, 13:123-37. 10.2147\/IMCRJ.S243405","journal-title":"Int Med Case Rep J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10882","article-title":"Next generation DNA sequencing of atypical choroid plexus papilloma of brain: identification of novel mutations in a female patient by Ion Proton","volume":"18","author":"Taher MM","year":"2019","unstructured":"Taher MM, Hassan AA, Saeed M, et al.. Next generation DNA sequencing of atypical choroid plexus papilloma of brain: identification of novel mutations in a female patient by Ion Proton. Oncol Lett. 2019, 18:5063-76. 10.3892\/ol.2019.10882","journal-title":"Oncol Lett"},{"key":"ref23","article-title":"Mutation profiling of intracranial myxopapillary ependymoma by next generation DNA sequencing","volume":"1","author":"Taher MM","year":"2021","unstructured":"Taher MM, Alhussini AA, Saeed M, et al.. Mutation profiling of intracranial myxopapillary ependymoma by next generation DNA sequencing. Gulf J Oncolog. 2021, 1:7-16.","journal-title":"Gulf J Oncolog"},{"key":"ref24","article-title":"Design and optimization of 18-gene Ion AmpliSeq panel of Next-generation sequencing for gene mutation analysis causing pain insensitivity","volume":"8","author":"Athar M","year":"2022","unstructured":"Athar M, Al-Allaf FA, Abduljaleel Z, Taher MM, Bouazzaoui A. Design and optimization of 18-gene Ion AmpliSeq panel of Next-generation sequencing for gene mutation analysis causing pain insensitivity. J Umm Al-Qura Univ Med Sci. 2022, 8:1-4.","journal-title":"J Umm Al-Qura Univ Med Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001091","article-title":"Modernizing reference genome assemblies","volume":"9","author":"Church DM","year":"2011","unstructured":"Church DM, Schneider VA, Graves T, et al.. Modernizing reference genome assemblies. PLoS Biol. 2011, 9:e1001091. 10.1371\/journal.pbio.1001091","journal-title":"PLoS Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1101\/gr.213611.116","article-title":"Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly","volume":"27","author":"Schneider VA","year":"2017","unstructured":"Schneider VA, Graves-Lindsay T, Howe K, et al.. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 2017, 27:849-64. 10.1101\/gr.213611.116","journal-title":"Genome Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp579","article-title":"Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data","volume":"25","author":"Degner JF","year":"2009","unstructured":"Degner JF, Marioni JC, Pai AA, Pickrell JK, Nkadori E, Gilad Y, Pritchard JK. Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data. Bioinformatics. 2009, 25:3207-12. 10.1093\/bioinformatics\/btp579","journal-title":"Bioinformatics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12247","article-title":"EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma","volume":"20","author":"Taher MM","year":"2020","unstructured":"Taher MM, Dairi G, Butt EM, et al.. EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma. Oncol Lett. 2020, 20:384. 10.3892\/ol.2020.12247","journal-title":"Oncol Lett"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182064d11","article-title":"PAX2(-)\/PAX8(-)\/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system","volume":"35","author":"Carney EM","year":"2011","unstructured":"Carney EM, Banerjee P, Ellis CL, et al.. PAX2(-)\/PAX8(-)\/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol. 2011, 35:262-7. 10.1097\/PAS.0b013e3182064d11","journal-title":"Am J Surg Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-641-MRCCTH","article-title":"Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease","volume":"131","author":"Polydorides AD","year":"2007","unstructured":"Polydorides AD, Rosenblum MK, Edgar MA. Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease. Arch Pathol Lab Med. 2007, 131:641-5. 10.5858\/2007-131-641-MRCCTH","journal-title":"Arch Pathol Lab Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao C","year":"2018","unstructured":"Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget. 2018, 9:5492-508. 10.18632\/oncotarget.23695","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida Y","year":"2003","unstructured":"Hoshida Y, Hongyo T, Jia X, et al.. Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China. Cancer Sci. 2003, 94:297-301. 10.1111\/j.1349-7006.2003.tb01436.x","journal-title":"Cancer Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.1670","article-title":"TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma","volume":"28","author":"Pfaff E","year":"2010","unstructured":"Pfaff E, Remke M, Sturm D, et al.. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol. 2010, 28:5188-96. 10.1200\/JCO.2010.31.1670","journal-title":"J Clin Oncol"},{"key":"ref34","article-title":"Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas","volume":"54","author":"Kanno H","year":"1994","unstructured":"Kanno H, Kondo K, Ito S, et al.. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res. 1994, 54:4845-7.","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38350","article-title":"Whole exome sequencing identified genetic variations in Chinese hemangioblastoma patients","volume":"173","author":"Ma D","year":"2017","unstructured":"Ma D, Yang J, Wang Y, Huang X, Du G, Zhou L. Whole exome sequencing identified genetic variations in Chinese hemangioblastoma patients. Am J Med Genet A. 2017, 173:2605-13. 10.1002\/ajmg.a.38350","journal-title":"Am J Med Genet A"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104359","article-title":"Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: an integrated evaluation of germline and somatic genomic results","volume":"64","author":"Rana HQ","year":"2021","unstructured":"Rana HQ, Koeller DR, Schwartz A, et al.. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: an integrated evaluation of germline and somatic genomic results. Eur J Med Genet. 2021, 64:104359. 10.1016\/j.ejmg.2021.104359","journal-title":"Eur J Med Genet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox034","article-title":"Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system","volume":"19","author":"Takayanagi S","year":"2017","unstructured":"Takayanagi S, Mukasa A, Tanaka S, et al.. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol. 2017, 19:1228-36. 10.1093\/neuonc\/nox034","journal-title":"Neuro Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152982-supratentorial-sporadic-hemangioblastoma-a-case-report-with-mutation-profiling-using-next-generation-dna-sequencing","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:19Z","timestamp":1707509119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152982-supratentorial-sporadic-hemangioblastoma-a-case-report-with-mutation-profiling-using-next-generation-dna-sequencing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.39818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}